Published in Biochem Biophys Res Commun on June 26, 2009
Myocardial AKT: the omnipresent nexus. Physiol Rev (2011) 1.76
Suppression of survival signalling pathways by the phosphatase PHLPP. FEBS J (2012) 1.23
Prospects for gene transfer for clinical heart failure. Gene Ther (2012) 0.87
MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation. Oncotarget (2015) 0.87
Beneficial effects of adenylyl cyclase type 6 (AC6) expression persist using a catalytically inactive AC6 mutant. Mol Pharmacol (2010) 0.87
mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2. Nat Commun (2016) 0.84
Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicity. Cell Death Dis (2014) 0.84
beta(1)-Adrenergic receptor vs adenylyl cyclase 6 expression in cardiac myocytes: differences in transgene localization and intracellular signaling. Cell Signal (2009) 0.80
Signaling Pathways in Cardiac Myocyte Apoptosis. Biomed Res Int (2016) 0.76
Ras-associating domain proteins: a new class of cyclic nucleotide-gated channel modulators. Adv Exp Med Biol (2012) 0.75
Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer. J Mol Cell Cardiol (2011) 0.75
The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer (2002) 28.11
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell (2006) 18.36
Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J (1996) 16.68
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell (2006) 11.48
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell (2006) 10.50
PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell (2005) 8.22
Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci (2001) 6.66
Perturbations of the AKT signaling pathway in human cancer. Oncogene (2005) 6.64
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell (2007) 6.00
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest (2005) 5.48
Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. Science (1997) 4.52
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev (2006) 2.96
Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A (2000) 2.65
Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation (2006) 2.18
Adenylyl cyclase increases survival in cardiomyopathy. Circulation (2002) 2.10
Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. Mol Cell (2006) 2.05
PHLiPPing the switch on Akt and protein kinase C signaling. Trends Endocrinol Metab (2008) 1.92
Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol (2004) 1.65
Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation (2007) 1.53
Truncation and alanine-scanning mutants of type I adenylyl cyclase. Biochemistry (1995) 1.48
Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. J Biol Chem (1997) 1.40
SCOP, a novel gene product expressed in a circadian manner in rat suprachiasmatic nucleus. FEBS Lett (1999) 1.31
Adenylyl cyclase type VI increases Akt activity and phospholamban phosphorylation in cardiac myocytes. J Biol Chem (2008) 1.15
Association of yeast adenylyl cyclase with cyclase-associated protein CAP forms a second Ras-binding site which mediates its Ras-dependent activation. Mol Cell Biol (2000) 1.06
New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy. Trends Cardiovasc Med (2007) 0.98
Modeling of Galpha(s) and Galpha(i) regulation of human type V and VI adenylyl cyclase. J Biol Chem (2004) 0.95
Structural determinants involved in the formation and activation of G protein betagamma dimers. Neurosignals (2009) 0.95
Intracellular distribution of adenylate cyclase in human cardiocytes determined by electron microscopic cytochemistry. Microsc Res Tech (1998) 0.90
Galphaq reduces cAMP production by decreasing Galphas protein abundance. Biochem Biophys Res Commun (2008) 0.87
Adenylyl cyclase: a new target for heart failure therapeutics. Circulation (2002) 0.83
Gene therapy in congestive heart failure. Circulation (2004) 0.80
Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem (2002) 2.66
Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction. Circulation (2006) 2.18
Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure. Circulation (2004) 2.01
Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation (2008) 1.56
Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice. J Am Coll Cardiol (2008) 1.35
Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. FASEB J (2007) 1.33
Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla. J Am Soc Nephrol (2010) 1.30
Targeted deletion of protein kinase C lambda reveals a distribution of functions between the two atypical protein kinase C isoforms. J Immunol (2004) 1.28
Loss of caveolin-1 accelerates neurodegeneration and aging. PLoS One (2010) 1.23
Actin polymerization in macrophages in response to oxidized LDL and apoptotic cells: role of 12/15-lipoxygenase and phosphoinositide 3-kinase. Mol Biol Cell (2003) 1.23
Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol (2011) 1.16
Adenylyl cyclase type VI increases Akt activity and phospholamban phosphorylation in cardiac myocytes. J Biol Chem (2008) 1.15
Regulation of oxygen utilization by angiotensin II in chronic kidney disease. Kidney Int (2008) 1.08
Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockade. Am J Physiol Renal Physiol (2010) 1.07
Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice. Am J Physiol Heart Circ Physiol (2004) 1.05
Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Mol Ther (2002) 1.05
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice. Am J Physiol Renal Physiol (2012) 1.00
Mitochondria-localized caveolin in adaptation to cellular stress and injury. FASEB J (2012) 0.99
New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy. Trends Cardiovasc Med (2007) 0.98
Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. J Biol Chem (2004) 0.97
Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC. Am J Pathol (2012) 0.96
A kinase interacting protein (AKIP1) is a key regulator of cardiac stress. Proc Natl Acad Sci U S A (2013) 0.94
Rho-mediated cytoskeletal rearrangement in response to LPA is functionally antagonized by Rac1 and PIP2. J Neurochem (2004) 0.93
Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology (2011) 0.92
Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase. Proc Natl Acad Sci U S A (2012) 0.91
Neuron-targeted caveolin-1 protein enhances signaling and promotes arborization of primary neurons. J Biol Chem (2011) 0.91
Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice. PLoS One (2013) 0.90
Adenylyl cyclase subtype-specific compartmentalization: differential regulation of L-type Ca2+ current in ventricular myocytes. Circ Res (2013) 0.90
Improved function of the failing rat heart by regulated expression of insulin-like growth factor I via intramuscular gene transfer. Hum Gene Ther (2012) 0.90
Comparison of adeno-associated virus serotypes and delivery methods for cardiac gene transfer. Hum Gene Ther Methods (2012) 0.89
In vivo gene knockdown in rat dorsal root ganglia mediated by self-complementary adeno-associated virus serotype 5 following intrathecal delivery. PLoS One (2012) 0.88
Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6. Hypertension (2011) 0.88
Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma. Cancer Biol Ther (2003) 0.87
Beneficial effects of adenylyl cyclase type 6 (AC6) expression persist using a catalytically inactive AC6 mutant. Mol Pharmacol (2010) 0.87
AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy. Mol Ther (2012) 0.86
Cardiac-directed expression of adenylyl cyclase VI facilitates atrioventricular nodal conduction. J Am Coll Cardiol (2006) 0.85
Intravenous adeno-associated virus serotype 8 encoding urocortin-2 provides sustained augmentation of left ventricular function in mice. Hum Gene Ther (2013) 0.84
Combinational spinal GAD65 gene delivery and systemic GABA-mimetic treatment for modulation of spasticity. PLoS One (2012) 0.84
Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice. Lab Invest (2012) 0.84
Disruption of adenylyl cyclase type V does not rescue the phenotype of cardiac-specific overexpression of Galphaq protein-induced cardiomyopathy. Am J Physiol Heart Circ Physiol (2010) 0.83
Adenylyl cyclase 6 mediates the action of cyclic AMP-dependent secretagogues in mouse pancreatic exocrine cells via protein kinase A pathway activation. J Physiol (2013) 0.81
beta(1)-Adrenergic receptor vs adenylyl cyclase 6 expression in cardiac myocytes: differences in transgene localization and intracellular signaling. Cell Signal (2009) 0.80
Preserved cardiac function despite marked impairment of cAMP generation. PLoS One (2013) 0.80
Preparation of vesicular stomatitis virus-G (VSV-G) conjugate and its use in gene transfer. Cold Spring Harb Protoc (2012) 0.79
Quantifying estrogen and progesterone receptor expression in breast cancer by digital imaging. J Histochem Cytochem (2005) 0.78
Cell-based GATA4 cardiac gene transfer using cell-penetrating peptide. Circ Res (2007) 0.77
Adenylyl cyclase 6 mediates loading-induced bone adaptation in vivo. FASEB J (2013) 0.76
Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenylyl cyclases in the ductus arteriosus. Circ Res (2010) 0.76
Gene therapy for myocardial infarction-associated congestive heart failure: how far have we got? Dialog Cardiovasc Med (2009) 0.75
TSA-SCC: Text Semantic-Aware Screen Content Coding with Ultra Low Bitrate. IEEE Trans Image Process (2022) 0.75